Dhaval Gosalia

Dhaval is an experienced global biopharmaceutical leader who consistently delivers measurable value for patients, customers, stakeholders, and the organization. He joined Glympse Bio from Merck and Co., Inc., where he held complex cross-functional leadership roles in Commercial, Finance, and R&D. In his last role, Dhaval was Executive Director for Commercial Strategy and Operations, where he developed and implemented Asia Pacific’s enterprise-level digital operating model. His commercial experience spans P&L management of therapeutic area business units, launching new products, operationalizing new alliances, leading product development, and portfolio management. Dhaval has also held roles as a Finance Leader and R&D Business Integrator, delivering performance improvement, resource optimization, and cost structure efficiencies through business process re-engineering and operating model innovation. Dhaval is a University of Pennsylvania graduate, where he received both his Ph.D. in Bioengineering and his MBA (Wharton)